Elisity's Customer Main Line Health Receives 2024 CSO Award for Cybersecurity Excellence

Elisity helps protect hospitals with “Health System Cyber Resilience through Chaos Engineering: Flattening the Curve of a Cyber Attack

SAN JOSE, Calif. November 13, 2024 --Elisity, the pioneer in identity-based microsegmentation, today announced its inclusion in a CSO award-winning project for the second consecutive year. This recognition highlights Main Line Health's proactive cybersecurity approach to protecting patient data and critical infrastructure.

Prompted by a surge in cyberattacks on healthcare, Main Line Health launched a proactive initiative to boost cyber resilience and ensure comprehensive protection across clinical care operations. Central to this effort are enterprise-wide two-hour downtime drills that simulate the transition from digital to analog care recordkeeping during a digital darkness event. This strategy addresses the dual challenges of ransomware attacks: financial impact and compromised patient safety.

The integration of Elisity’s rapid deployment and microsegmentation capabilities during Main Line’s limited downtime windows has significantly enhanced its network security posture. This ensures the seamless transition from paper to digital records post-downtime and enhances cyber resilience, minimizing potential financial and reputational impacts. The organization effectively safeguards its revenue cycle and upholds its reputation by maintaining the integrity of patient care and documentation during downtimes.

“Elisity’s role in this initiative showcases our commitment to providing advanced cybersecurity solutions to protect digital infrastructure and ensure operational resilience,” said James Winebrenner, CEO, Elisity. “By collaborating with leading vendors and adopting cutting-edge technologies, Main Line Health has set a benchmark for protecting patient safety and ensuring healthcare continuity. We are honored to be recognized for the second year in a row alongside the 2023 winners, GSK”

Main Line Health's integration with Armis and CrowdStrike through Elisity has enhanced its defense-in-depth strategy, providing granular control over the network and ensuring a swift and precise response to potential threats. This integration has also driven business development and realignment decisions based on medical device utilization patterns.

“The synergy between Armis, CrowdStrike, and Elisity has fortified defenses against targeted cyber threats, improving overall operational efficiency with added layers of security and visibility,” said Aaron Weismann, Chief Information Security Officer for Main Line Health. “This year's award specifically recognizes the System’s success in adopting broad-based and clinically focused innovative approaches to patient care continuity during a cyberattack.”

The full 2024 CSO Award winners list can be found here.

A replay of a discussion between Elistiy and Main Line Health’s Aaron Weismann, Chief Information Security Officer, can be found here, 

About Elisity

Elisity is a leap forward in network segmentation architecture and is leading the enterprise effort to achieve Zero Trust maturity, proactively prevent security risks, and reduce network complexity. Designed to be implemented in days, without downtime, upon implementation, the platform rapidly discovers every device on an enterprise network and correlates comprehensive device insights into the Elisity IdentityGraph™. This empowers teams with the context needed to automate classification and apply dynamic security policies to any device wherever and whenever it appears on the network. These granular, identity-based microsegmentation security policies are managed in the cloud and enforced using your existing network switching infrastructure in real-time, even on ephemeral IT/IoT/OT devices. Founded in 2019, Elisity has a global employee footprint and a growing number of customers in the Fortune 500.

About Main Line Health

Founded in 1985, Main Line Health is a not-for-profit health system serving Philadelphia and its suburbs. Main Line Health's commitment — to deliver safe, high-quality, equitable and affordable care for treating and curing disease, playing an important role in prevention and disease management, as well as training physicians and other health care providers — reflects our intent to be the region's premier choice for clinical care, research, and education. A team of more than 13,000 employees and over 3,500 employed and independent physicians and advanced practice providers care for patients throughout Main Line Health.

At Main Line Health's core are four of the region's most respected acute care hospitals — Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital — as well as one of the nation's premier facilities for rehabilitative medicine, Bryn Mawr Rehab Hospital.

Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region's largest multispecialty physician networks.

Main Line Health is the recipient of numerous awards for quality care and service, including the prestigious American Hospital Association Quest for Quality Prize, highest tier ratings from the Centers for Medicare & Medicaid Services (CMS) for Overall Hospital Quality and systemwide recognition in the 2023-2024 U.S. News & World Report Best Hospitals rankings. Main Line Health is committed to creating an environment of diversity, respect, equity and inclusion, has proudly received awards in this area and has embraced the American Hospital Association's #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help patients stay healthy and live their best lives.

Contacts
Leslie Kesselring
Kesselring Communications for Elisity
leslie@kesscomm.com